Physician
Rheumatology
Dr. Anthony I. Sebba, MD
|
|
Give Review
Dr. Anthony I. Sebba practices Rheumatology. He attended Mount Sinai School of Medicine. He received awards:"Fellow", "Fellow (FACR)" and "Top MD". Anthony I. Sebba, MD has written publications. He has 21 publications published with PubMed. The lastest publication is: '[Intravenous digital angiography in the kidney transplant patient: results of a systematic prospective study in 164 patients].' He is registered with Medicare.
Publications
- The Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) study: 2-year nonvertebral fragility fracture results.
- A safety analysis of oral prednisone as a pretreatment for rituximab in rheumatoid Arthritis.
- Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid Arthritis: results of a 12-week, phase II, dose-finding study.
- Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid Arthritis: the AMBITION study.
- Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.
- Vertebral fracture risk is reduced in women who lose femoral Neck BMD with teriparatide treatment.
- Comparing non-vertebral fracture risk reduction with Osteoporosis therapies: looking beneath the surface.
- Prediction of changes in bone mineral density in postmenopausal women treated with once-weekly bisphosphonates.
- Ibandronate dose response is associated with increases in bone mineral density and reductions in clinical fractures: results of a meta-analysis.
- Osteoporosis: how long should we treat?
- Tocilizumab: the first interleukin-6-receptor inhibitor.
- Rapid suppression of bone resorption marker levels with ibandronate therapy in a bisphosphonate-naïve population.
- Significance of a decline in bone mineral density while receiving oral bisphosphonate treatment.
- Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoArthritis in two identically designed, randomized, placebo-controlled, non-inferi...
- Comparison of weekly treatment of postmenopausal Osteoporosis with alendronate versus risedronate over two years.
- Optimizing administration of bisphosphonates in women with postmenopausal Osteoporosis.
- Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal Osteoporosis.
- Hydroxychloroquine concentration-response relationships in patients with rheumatoid Arthritis.
- Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid Arthritis: a randomized, double-blind six-week trial with eighteen-week ...
- [Intravenous digital angiography in the kidney transplant patient: results of a systematic prospective study in 164 patients].
Procedures Preformed
- Biological Therapy
- Bone Density Scan
- Bursa Injection
- Infusion Therapy
- View All
Conditions Treated
- Ankylosing Spondylitis
- Arthritis
- Behçet's Disease
- Bursitis
- View All
Doctors Specialties
- Rheumatology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Open Access
- Group Plan PPO
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Medicaid
- Medical Mutual of Ohio
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Options PPO
- United Healthcare
- WellCare PPO
- WellPoint
Awards
- Fellow
- Fellow (FACR)
- Top MD
Education
-
Mount Sinai School of Medicine -
Bronx-Lebanon Hospital Center -
University of Cape Town Faculty of Medicine
Drug Facts
| NPI NUMBER | 1629077243 | |
| NPPES Provider LastName | SEBBA | |
| NPPES Provider FirstName | ANTHONY | |
| NPPES Provider ZIPCode | 34684 | |
| NPPES Provider State | FL | |
| Specialty Description | Rheumatology | |
| Total Claim Count | 1305.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 71.0 | |
| Percent Opioid Claims | 5.44 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1629077243 |
| Last Name Of The Provider | SEBBA |
| First Name Of The Provider | ANTHONY |
| View All |
Similar Doctors
|
|
Dr. Karen E. Zagar, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria C. Soto-Aguilar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mitchell B. Lowenstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Priya Sadanandan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carlos M. Ganuza, MD |
|
|
Dr. Tatiana P. Nagibina, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen E. Rendt-Zagar, MD |
|
|
Linda J. Mangione, PA-C |